Experts examine the reasoning behind a steep rise in tick-borne illnesses, such as Lyme disease, in the United States and discuss the best ways to thwart this serious public health threat.
As a ZPIV vaccine had proved to be well tolerated and immunogenic at up to 8 weeks of follow-up, investigators evaluated the safety and immunogenicity of ZPIV at up to 52 weeks of follow-up using a standard or accelerated vaccination schedules.
Findings in a case report in Morbidity and Mortality Weekly Report suggest the possibility that exposure to Trypanosoma cruzi occurred locally in Missouri.
Researchers at the University of California San Diego have identified a target gene in mosquitos that renders the insects completely refractory to all 4 serotypes of the dengue virus and thus, incapable of transmitting the virus to humans, according to study results published in PLoS Pathogens.1 Dengue fever is caused by infection with 1 of…
Researchers evaluated the frequency of polyautoimmunity and its associated factors in a large retrospective cohort of patients with systemic lupus erythematosus.
Study data demonstrates an early benefit to receiving Japanese Encephalitis vaccination prior to CYD-TDV in terms of higher overall anti-dengue virus neutralizing titers, although this benefit appears to wane after several months.
Researchers reviewed the recently released Lyme disease guidelines and addressed their appropriate inclusion of and association with psychiatric illnesses.
For patients with normal glucose-6-phosphate dehydrogenase activity in malaria-endemic areas where frequent relapsing strains of Plasmodium vivax are prevalent, a 7-day high-dose course of primaquine was noninferior to a 14-day course.
Eli Lilly was the only pharmaceutical company providing quinidine gluconate in the United States, but in November 2017 it stopped manufacturing the drug and the remaining supplies expired.
In patients with malaria who have normal levels of glucose-6-phosphate dehydrogenase, 7-day primaquine was well tolerated and noninferior to 14-day primaquine.
